Results 51 to 60 of about 1,554,916 (325)
Student's Journal of Health Research Africa, 2023 Background: The main purpose of the study was to determine the factors contributing to low response towards COVID-19 vaccination among residents of Acoo village, Kole district.
Monica Amolo , Richard Kanyesigye
doaj +1 more source
, 2020 Covid-19 has caused hundred of thousands of deaths and an economic damage amounting to trillions of dollars, creating a desire for the rapid development of vaccine.
Grauer, Jens +2 more
core +1 more source
Prevention of infection and disruption of the pathogen transfer chain in elective surgery [PDF]
, 2020 The COVID-19 pandemic has caused us all to stop our normal activities and consider how we can safely return to caring for our patients. There are many common practices (such as an increased use of personal protective equipment) which we are all familiar ...
Chisari, Emanuele +5 more
core +2 more sources
Predictors of COVID-19 vaccine hesitancy in the UK household longitudinal study
Brain, behavior, and immunity, 2021 Vaccine hesitancy could undermine efforts to control COVID-19. We investigated the prevalence of COVID-19 vaccine hesitancy in the UK and identified vaccine hesitant subgroups.
E. Robertson +7 more
semanticscholar +1 more source
Will COVID-19 mark the end of an egalitarian NHS? [PDF]
, 2020 The exceptional circumstances brought about by the COVID-19 pandemic have affected the traditional organisation of healthcare resources allocation in the UK. Since its inception, the National Health Service (NHS) has aimed to regulate risks of ill health
Germain, S.
core +1 more source
Human Vaccines & Immunotherapeutics, 2020 Background The development of a vaccine against SARS-CoV-2 infection is on the way. To prepare for public availability, the acceptability of a hypothetical COVID-19 vaccine and willingness to pay (WTP) were assessed to provide insights into future demand
L. Wong +4 more
semanticscholar +1 more source
Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial
Science, 2021 Description Antibody levels predict vaccine efficacy Symptomatic COVID-19 infection can be prevented by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines.
P. Gilbert +39 more
semanticscholar +1 more source
COVID-19 Vaccine Development to Vaccination
Journal of Nepal Health Research Council, 2021 In the race for a safe and effective vaccine against Coronavirus disease-19 manufacturer plays a critical role throughout the development, clinical trial, manufacturing, supply, and vaccination phases. For the efficacy of Coronavirus disease-19 vaccine, proper transport, storage, vaccine carrier, adjuvant, dosage form and route of vaccine ...
Ashok Pandey +2 more
openaire +2 more sources
Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons
New England Journal of Medicine, 2021 Background Many pregnant persons in the United States are receiving messenger RNA (mRNA) coronavirus disease 2019 (Covid-19) vaccines, but data are limited on their safety in pregnancy.
T. Shimabukuro +20 more
semanticscholar +1 more source
Microbial Pathogenesis, 2022 As of 2022, the global population has access to several mRNA and traditional inactivated vaccines. However, their effectiveness in preventing infection, hospitalization, and COVID-associated mortality in Jordan has yet to be evaluated. The purpose of this observational study was to evaluate the relative effectiveness of three approved vaccines against ...
Mohamed J. Saadh, Saif Aldeen Jaber
openaire +2 more sources